Article
Dec 10, 2025

Stephen Matta, DO, MBA, CAQSM

Dr. Stephen Matta, DO, MBA, CAQSM, is a triple board-certified physician in Family Medicine, Sports Medicine, and Stem Cell Therapy. He is co-founder of Meeting Point Health in Philadelphia. Specializing in regenerative orthopedics, anti-aging, and cellular medicine, he integrates holistic therapies like ultrasound-guided regenerative injections with orthobiologics, osteopathic manipulation, peptide and hormone therapy, and medical acupuncture to address chronic pain and nervous system dysregulation. A graduate of Philadelphia College of Osteopathic Medicine, Dr. Matta completed his residency at Valley Baptist Family Practice in Texas, and a fellowship in Primary Care Sports Medicine at Mountainside Sports Medicine in New Jersey. His East-meets-West approach, co-developed with his wife, Mary Anne Matta, emphasizes root-cause solutions, utilizing peptides, ozone therapy, and stem cell therapy. Formerly a team physician for the Antigua Professional Soccer Team and NJIT Division I sports, Dr. Matta is a Fellow of the SSRP Institute and a sought-after speaker. His comprehensive assessments and patient-centered care have transformed lives, earning him a reputation as a master diagnostician dedicated to unlocking human potential through integrative medicine.

RELATED RESOURCES

Continue exploring related topics.

VIEW ALL
ARTICLE
William Seeds, MD
May 14, 2026
How the Peptide AOD-9604 Targets LanCL Proteins to Fight Viral Infections and Neurodegenerative Conditions 
William Seeds, MD May 14, 2026
How the Peptide AOD-9604 Targets LanCL Proteins to Fight Viral Infections and Neurodegenerative Conditions 
In this research article, I return to the subject of my first-ever Journal Club (Ep. 017), in which I discussed a 2023 research study entitled, “Naturally derived cytokine peptides limit virus replication and severe disease during influenza A virus infection” (2023) that examined a specific growth hormone-derived peptide to address the underlying immunological mechanisms of post-viral […]
READ ARTICLE
VIDEO
Cellular Medicine Mondays
May 11, 2026
Ep. 087 - The Renin–Angiotensin–Aldosterone System (RAAS): Beyond Cardiovascular Regulation
Preview Only
Journal Club – Episode 087

The Renin–Angiotensin–Aldosterone System (RAAS): Beyond Cardiovascular Regulation

Dr. Seeds unpacks how RAS receptor balance drives inflammation, fibrosis, mitochondrial dysfunction, and tissue remodeling, far beyond its classical role in blood pressure regulation. (Article Link)

Preview Only — Become a member for full access
SSRP Institute May 6, 2026
Nutrition Education for Physicians and Medical Students
HEADLINE SCIENCE MAY 6, 2026 —Earlier in March, the U.S. Department of Health and Human Services (HHS) and the U.S. Department of Education announced an initiative to emphasize nutrition at the nation’s top medical schools. Reflecting U.S. Health and Human Services Secretary Robert Kennedy’s commitment to preventative medicine, this initiative will require “meaningful nutrition training” […]
READ NEWS
VIDEO
Cellular Medicine Mondays
May 4, 2026
Ep. 086 - May '26
Preview Only
SSRP Institute Apr 29, 2026
New ACC and AHA Cholesterol Management Guidelines
HEADLINE SCIENCE APRIL 29, 2026 – The American College of Cardiology (ACC) and American Heart Association (AHA) have updated their cholesterol management guidelines, advocating for earlier and more aggressive intervention based on the understanding that cumulative lifetime exposure to high LDL-C drives atherosclerotic cardiovascular disease (ASCVD) risk. The guidelines aim to standardize care for dyslipidemia […]
READ NEWS
VIDEO
Cellular Medicine Mondays
Apr 27, 2026
Ep. 085 - Peptide Pharmacokinetics
Preview Only
Dissecting Protocols – Episode 085

Peptide Pharmacokinetics

Dissecting Protocols, Dr. Seeds breaks down the reasoning behind SubQ vs. IM peptide administration. From pharmacokinetic considerations to the growing misuse of combining peptides with oil-based medications in the same syringe, this discussion helps clarify proper application and safety considerations.

Preview Only — Become a member for full access
ARTICLE
William Seeds, MD
Apr 21, 2026
A Review of Circadian Processes and Evidence-Based Interventions to Improve Sleep
William Seeds, MD Apr 21, 2026
A Review of Circadian Processes and Evidence-Based Interventions to Improve Sleep
Introduction In March of this year, I did a Rabbit Hole (Episode 079) in which I discussed a number of trends marketed to the wider public promising sleep improvement. As you know, a huge swath of the population suffers from sleep disturbance. According to the NIH, approximately 30% to 40% of US adults report sleep […]
READ ARTICLE
VIDEO
Cellular Medicine Mondays
Apr 20, 2026
Ep. 084 - The Cellular Impact of UVA vs. UVB Light (Part 2)
Preview Only
Rabbit Holes – Episode 084

The Cellular Impact of UVA vs. UVB Light (Part 2)

Dr. Seeds continues this Rabbit Hole on UVA vs. UVB light in Part 2, covering oxidative stress, skin aging, vitamin D synthesis, and the risks of tanning beds. A helpful look at why not all UV exposure works the same, why that distinction matters, and how it shapes both skin health and cellular function

Catch Part 1 (Rabbit Holes – Ep. 081) HERE

Preview Only — Become a member for full access
SSRP Institute Apr 15, 2026
FDA Announces Change in Status of 12 Peptides
BREAKING NEWS APRIL 15, 2026 – In a welcome announcement to the SSRP community, the FDA reported today that it will imminently remove the following bulk drug substances from category 2: BPC-157, LL-37, DiHexa, DSIP, Epitalon, *GHK-Cu (injectable only), KPV, PEG-MGF, Melanotan II, MOTs-C, Semax, and TB-500. Originally nominated for Category 2 (Bulk Substances that […]
READ NEWS
VIDEO
Cellular Medicine Mondays
Apr 13, 2026
Ep. 083 - Safety of Low-Dose Oral Minoxidil for Hair Loss: A Multicenter Study of 1404 Patients
Preview Only
Journal Club – Episode 083

Safety of Low-Dose Oral Minoxidil for Hair Loss: A Multicenter Study of 1404 Patients

Dr. Seeds discusses this article on low dose minoxidil for hair loss and shares why a lower, slower dosing approach may lead to better outcomes. He also reviews key safety considerations, side effects, and practical dosing insights for both men and women. (Article Link)

Preview Only — Become a member for full access

Subscribe to the SSRP Community Digest

Get the latest research and developments in the field of Cellular Medicine straight to your inbox every month.

This field is for validation purposes and should be left unchanged.